Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 09, 2022, titled "Glenmark launches Nitric Oxide Nasal Spray (FabiSpray��) in India for the Treatment ofAdult Patients with COVID‐19 in partnership with SaNOtize".